These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 34412701)

  • 1. Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery.
    Hunter M; Spiller KJ; Dominique MA; Xu H; Hunter FW; Fang TC; Canter RG; Roberts CJ; Ransohoff RM; Trojanowski JQ; Lee VM
    Acta Neuropathol Commun; 2021 Aug; 9(1):140. PubMed ID: 34412701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy.
    Spiller KJ; Restrepo CR; Khan T; Dominique MA; Fang TC; Canter RG; Roberts CJ; Miller KR; Ransohoff RM; Trojanowski JQ; Lee VM
    Nat Neurosci; 2018 Mar; 21(3):329-340. PubMed ID: 29463850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration.
    Dutta K; Patel P; Rahimian R; Phaneuf D; Julien JP
    Neurotherapeutics; 2017 Apr; 14(2):447-462. PubMed ID: 27928708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy.
    Tsitkanou S; Della Gatta PA; Abbott G; Wallace MA; Lindsay A; Gerlinger-Romero F; Walker AK; Foletta VC; Russell AP
    Neurobiol Dis; 2022 Jan; 162():105559. PubMed ID: 34774794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.
    Walker AK; Spiller KJ; Ge G; Zheng A; Xu Y; Zhou M; Tripathy K; Kwong LK; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2015 Nov; 130(5):643-60. PubMed ID: 26197969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy.
    Spiller KJ; Cheung CJ; Restrepo CR; Kwong LK; Stieber AM; Trojanowski JQ; Lee VM
    J Neurosci; 2016 Jul; 36(29):7707-17. PubMed ID: 27445147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow motor neurons resist pathological TDP-43 and mediate motor recovery in the rNLS8 model of amyotrophic lateral sclerosis.
    Hur SK; Hunter M; Dominique MA; Farag M; Cotton-Samuel D; Khan T; Trojanowski JQ; Spiller KJ; Lee VM
    Acta Neuropathol Commun; 2022 May; 10(1):75. PubMed ID: 35568882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS.
    Mitchell JC; Constable R; So E; Vance C; Scotter E; Glover L; Hortobagyi T; Arnold ES; Ling SC; McAlonis M; Da Cruz S; Polymenidou M; Tessarolo L; Cleveland DW; Shaw CE
    Acta Neuropathol Commun; 2015 Jun; 3():36. PubMed ID: 26108367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytosis of aggrecan-positive perineuronal nets surrounding motor neurons by reactive microglia expressing MMP-9 in TDP-43
    Cheung SW; Willis EF; Simmons DG; Bellingham MC; Noakes PG
    Neurobiol Dis; 2024 Oct; 200():106614. PubMed ID: 39067491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain.
    Swanson MEV; Mrkela M; Murray HC; Cao MC; Turner C; Curtis MA; Faull RLM; Walker AK; Scotter EL
    Acta Neuropathol Commun; 2023 Apr; 11(1):69. PubMed ID: 37118836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD.
    Kumar S; Phaneuf D; Cordeau P; Boutej H; Kriz J; Julien JP
    Mol Neurodegener; 2021 Jan; 16(1):1. PubMed ID: 33413517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice.
    Perera ND; Sheean RK; Crouch PJ; White AR; Horne MK; Turner BJ
    Hum Mol Genet; 2016 Sep; 25(18):4080-4093. PubMed ID: 27466204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor neuron translatome reveals deregulation of SYNGR4 and PLEKHB1 in mutant TDP-43 amyotrophic lateral sclerosis models.
    Marques RF; Engler JB; Küchler K; Jones RA; Lingner T; Salinas G; Gillingwater TH; Friese MA; Duncan KE
    Hum Mol Genet; 2020 Sep; 29(16):2647-2661. PubMed ID: 32686835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosis.
    Wright AL; Della Gatta PA; Le S; Berning BA; Mehta P; Jacobs KR; Gul H; San Gil R; Hedl TJ; Riddell WR; Watson O; Keating SS; Venturato J; Chung RS; Atkin JD; Lee A; Shi B; Blizzard CA; Morsch M; Walker AK
    Eur J Neurosci; 2021 Sep; 54(6):6237-6255. PubMed ID: 34390052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency.
    Zhang J; Velmeshev D; Hashimoto K; Huang YH; Hofmann JW; Shi X; Chen J; Leidal AM; Dishart JG; Cahill MK; Kelley KW; Liddelow SA; Seeley WW; Miller BL; Walther TC; Farese RV; Taylor JP; Ullian EM; Huang B; Debnath J; Wittmann T; Kriegstein AR; Huang EJ
    Nature; 2020 Dec; 588(7838):459-465. PubMed ID: 32866962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early activation of cellular stress and death pathways caused by cytoplasmic TDP-43 in the rNLS8 mouse model of ALS and FTD.
    Luan W; Wright AL; Brown-Wright H; Le S; San Gil R; Madrid San Martin L; Ling K; Jafar-Nejad P; Rigo F; Walker AK
    Mol Psychiatry; 2023 Jun; 28(6):2445-2461. PubMed ID: 37012334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FUS(1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy.
    Funikov SY; Rezvykh AP; Mazin PV; Morozov AV; Maltsev AV; Chicheva MM; Vikhareva EA; Evgen'ev MB; Ustyugov AA
    Neurogenetics; 2018 Aug; 19(3):189-204. PubMed ID: 29982879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.
    Igaz LM; Kwong LK; Lee EB; Chen-Plotkin A; Swanson E; Unger T; Malunda J; Xu Y; Winton MJ; Trojanowski JQ; Lee VM
    J Clin Invest; 2011 Feb; 121(2):726-38. PubMed ID: 21206091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.
    Butovsky O; Jedrychowski MP; Cialic R; Krasemann S; Murugaiyan G; Fanek Z; Greco DJ; Wu PM; Doykan CE; Kiner O; Lawson RJ; Frosch MP; Pochet N; Fatimy RE; Krichevsky AM; Gygi SP; Lassmann H; Berry J; Cudkowicz ME; Weiner HL
    Ann Neurol; 2015 Jan; 77(1):75-99. PubMed ID: 25381879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.